Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous artificial oxygen carriers.

Daniel Farrar1, Mike Grocott

  • 1Centre for Anaesthesia, University College London, London W1T 3AA.

Hospital Medicine (London, England : 1998)
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BMI and its association with patient-reported outcome measures following revision hip surgery.

Bone & joint open·2026
Same author

Correction: The Perioperative Quality Improvement Programme (PQIP patient study): protocol for a UK multicentre, prospective cohort study to measure quality of care and outcomes after major surgery.

Perioperative medicine (London, England)·2025
Same author

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Gut·2025
Same author

Gabapentin for Pain Management after Major Surgery: A Placebo-controlled, Double-blinded, Randomized Clinical Trial (the GAP Study).

Anesthesiology·2025
Same author

The Impact of Prehabilitation on Patient Outcomes in Oesophagogastric Cancer Surgery: Combined Data from Four Prospective Clinical Trials Performed Across the UK and Ireland.

Cancers·2025
Same author

Improving physical function with physiotherapy assistants following intensive care unit admission (EMPRESS): A randomised controlled feasibility study.

Journal of the Intensive Care Society·2025
Same journal

Management of non-thrombolysable acute coronary syndrome (ACS).

Hospital medicine (London, England : 1998)·2005
Same journal

Case report: treatment of faecaloma of the colon.

Hospital medicine (London, England : 1998)·2005
Same journal

Should anaesthetists scrub? The case for and against.

Hospital medicine (London, England : 1998)·2005
Same journal

Angiosarcoma: a difficult diagnosis.

Hospital medicine (London, England : 1998)·2005
Same journal

Pitfalls in recurrent varicose vein surgery.

Hospital medicine (London, England : 1998)·2005
Same journal

Aorto-caval fistula.

Hospital medicine (London, England : 1998)·2005
See all related articles

Artificial oxygen carriers like haemoglobin-based oxygen carriers and perfluorocarbons show promise for intravenous administration. However, mixed clinical trial results indicate more research is needed to confirm their efficacy and safety.

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Anesthesiology

Background:

  • Artificial oxygen carriers, including haemoglobin-based oxygen carriers (HBOCs) and perfluorocarbons (PFCs), are being developed for intravenous use.
  • These products aim to supplement or replace traditional oxygen transport methods.

Purpose of the Study:

  • To review the current status and clinical potential of artificial oxygen carriers.
  • To assess the safety and efficacy of HBOCs and PFCs based on existing clinical trial data.

Main Methods:

  • Review of existing literature on haemoglobin-based oxygen carriers and perfluorocarbons.
  • Analysis of clinical trial outcomes regarding safety and efficacy.

Main Results:

Related Experiment Videos

  • Haemoglobin-based oxygen carriers and perfluorocarbons can be safely administered intravenously.
  • Clinical trials have yielded mixed results, highlighting variability in outcomes.

    • Conclusions:

    • Further research is essential to establish the definitive clinical efficacy and safety of artificial oxygen carriers.
    • Additional studies are required to optimize product development and clinical application.